Intrathecal Morphine for Robotic-assisted Laparoscopic Hysterectomy.

Karlstad Central Hospital

Status: Completed

Conditions: Opioid-Related Disorders

Treatments: Procedure: Robotic-assisted hysterectomy

Study type: Interventional

Funder types: Other

Identifiers

NCT04675840

KarlstadCH

Details and patient eligibility

About

Is there any difference in the intensity of postoperative pain, nausea, urinary retention and legth of hospital stay in patients undergoing robotic assisted laparoscopic surgery if they receive intrathecal morphine or peroral and intravenous opiates during the surgery and is there a significant difference in the need of opiates after the surgery.

Enrollment: 100 patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

* Patients accepted for robotic-assisted laparoscopic surgery

Exclusion criteria

• Coagulopathy,
• Prior spine surgery,
• Chronic pain problems,
• Drug abuse,
• Pregnancy
• < 18 years

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

100 participants in 2 patient groups

intrathecal morphine

Active Comparator group

Description:

Spinal injection of 15mg Bupivakain and 0,25mg morphine before surgery.

Treatment:

Procedure: Robotic-assisted hysterectomy

opiate po/iv

Active Comparator group

Description:

Patient given 10mg Oxycodone orally before surgery.

Treatment:

Procedure: Robotic-assisted hysterectomy